2025 Event Guide
Download the Guide to Discover:
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Real-world data from Regeneron, AbbVie & Novartis on minimizing immunogenicity to enable repeat dosing, expand patient eligibility, and improve clinical outcomes
Next-generation capsids with Dyno Therapeutics and Avista Therapeutics designed to overcome AAV limitations, reduce off-target effects, and achieve safer, more scalable delivery across CNS and muscle indications
Translational insights from clinical-stage programs tackling pre-existing antibodies and immune barriers featuring case studies from ExcisionBio Therapeutics, Vivet Therapeutics, and 4DMT
Decision-makers at the forefront of gene therapy innovation you can connect with, who will be sharing new tools for predictive modelling, antibody clearance, and precision diagnostics to transform patient selection and trial success
Companies on the Program Include:
